For start-ups and established corporations alike, ESOPs serve a dual purpose: preserving immediate cash flows while aligning employee interests with long-term shareholder wealth.

However, from a corporate governance, financial accounting, and shareholder perspective, ESOPs are far from “free” equity. They come with real structural compromises—specifically ownership dilution and quantifiable corporate costs.

The Cap Table Reality Check

When institutional investors or auditors evaluate a company’s capital structure, they do not just look at currently issued equity. They look at the fully diluted cap table, which accounts for four primary components:

[Fully Diluted Cap Table] ├── 1. Actual Issued Shares (Currently outstanding) ├── 2. Options Granted but Unvested (Earmarked for future vesting) ├── 3. Options Vested but Unexercised (Awaiting employee action) └── 4. Unallocated ESOP Pool Balance (Reserved for future hires)

Is an ESOP Truly a Cost?

A common point of debate in corporate boardrooms is whether granting stock options constitutes a genuine business expense, given that no actual cash leaves the corporate bank account. Legally and financially, ESOPs are as much a corporate cost as monthly payroll or performance bonuses. To understand why, we must evaluate how the chosen Exercise Price (the price the employee pays to buy the share) interacts with the Market Price at different stages of the option lifecycle.

1. The value proposition is governed by two components:
2. Intrinsic Value: The immediate discount offered on the date of grant.
3. Time Value: The upside or premium that accrues on the share price between the date of the grant and the eventual date of exercise.

 

The 3 Grant Price Scenarios

The strategic utility and accounting treatment of an ESOP depend entirely on how the exercise price is set relative to the prevailing market price on the date of grant

Scenario A: Options Granted at Market Price (Zero Intrinsic Value)

When a company sets the exercise price exactly equal to the current market price on the date of grant, the Intrinsic Value is Nil.

The Employee Benefit: The employee receives the right to purchase the equity at a later date without paying upfront for any future “Time Value” appreciation. Crucially, the employee captures 100% of the market upside while being completely shielded from any downside risk. If the stock drops below the grant price, they simply choose not to exercise, incurring zero financial loss.

The Corporate Impact: Because there is no immediate discount, the upfront accounting cost to the company is lower. However, if the stock price stagnates, these options become “underwater” and lose all motivational value.

Scenario B: Options Granted with a Discount (High Intrinsic Value)

When a company offers options at an exercise price lower than the current market price on the date of grant, it creates immediate Intrinsic Value, alongside the future Time Value.

The Employee Benefit: The employee gains an immediate financial cushion. Upon exercise, they acquire equity without paying the differential between the market value and their discounted strike price.

The Corporate Impact: By providing equity at a steep discount, the company deliberately forgoes its claim to a higher cash inflow that it would have otherwise received if it sold those same shares to an open-market investor. This missed premium is economically identical to a cash expense. Furthermore, because employees only exercise options when the strike price is lower than the fair market value, the transaction inherently reduces the company’s market capitalization on a per-share basis upon exercise, resulting in a direct drop in shareholder value.

Scenario C: Options Granted Above Market Price (Premium Pricing)

If a company sets the exercise price higher than the current market value on the date of grant, the options are born “out of the money.” This structure behaves exactly like a direct market purchase of shares. It offers zero immediate value and provides very little motivation to workforce personnel, making it practically redundant in modern corporate compensation strategies.

Conclusion: Recognizing that ESOPs are a true corporate expense introduces critical follow-up governance questions for management: When exactly should this cost be recognized in the profit & loss statement? How do we accurately quantify the “Time Value” at the grant date using option pricing models like Black-Scholes? And what are the tax implications when these options convert to actual equity? Navigating these regulatory milestones with precision ensures that your company continues to attract top-tier talent without inadvertently compromising long-term investor trust.

Article by: CS Neha Sarpal(91-7053715771)

Disclaimer: This article provides a comprehensive overview of equity incentives under Indian law for informational and educational purposes. It does not constitute formal legal or tax advice. Corporate boards must consult an independent Registered Valuer and qualified legal counsel to customize schemes matching their specific corporate structures.